NCT06501911 A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma Status WITHDRAWN Phase PHASE1
NCT06389591 RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM) Status RECRUITING Phase PHASE1
NCT06344130 Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma Status RECRUITING Phase PHASE1
NCT06325683 Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma Status SUSPENDED Phase PHASE2
NCT06283927 The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) Status RECRUITING Phase N/A
NCT06273176 The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma Status RECRUITING Phase N/A
NCT06220552 The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma Status RECRUITING Phase PHASE2
NCT06186401 Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells Status RECRUITING Phase PHASE1
NCT06160206 Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma Status RECRUITING Phase PHASE2
NCT06097975 A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma Status RECRUITING Phase PHASE1
NCT06090903 Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma Status RECRUITING Phase NA
NCT06069726 A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial Status RECRUITING Phase PHASE2
NCT06058988 Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer Status RECRUITING Phase PHASE2
NCT05977738 Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin Status COMPLETED Phase EARLY_PHASE1
NCT05902169 Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM Status RECRUITING Phase PHASE3
NCT05879120 Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma Status WITHDRAWN Phase PHASE2
NCT05802693 A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT05798507 Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1